A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide

Akira Terano, Tetsuo Arakawa, Toshiro Sugiyama, Toshikazu Yoshikawa, Ken Haruma, Masahiro Asaka, Tooru Shimosegawa, Nobuhiro Sakaki, Hiromasa Ishii, Choitsu Sakamoto, Shin Ichi Takahashi, Yoshikazu Kinoshita, Toshio Fujioka, Kenzo Kobayashi

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Background and Aim: Controversies remain over the need for antiulcer treatment following 1-week eradication triple therapy for Helicobacter pylori-positive peptic ulcers. The usefulness of combination therapy for gastric ulcers in Japanese patients, which consists of H. pylori eradication followed by gastroprotective therapy with rebamipide, was therefore evaluated. Methods: The study was conducted in 52 H. pylori-positive patients with an endoscopically-proven open gastric ulcer. All patients received 1-week triple therapy (lansoprazole, amoxicillin and clarithromycin) followed by 7-week rebamipide therapy. After completion of the combination therapy, all patients underwent evaluation of ulcer healing by endoscopy, gastric ulcer symptoms and H. pylori eradication by rapid urease test and 13C-urea breath test. Results: The ulcer healing rates were 85.7% (36/42) at 8 weeks, 83.3% (30/36) in eradicated patients and 100% (6/6) in non-eradicated patients. The overall gastrointestinal symptom-free rate improved from 19.0% at baseline to 88.1% at 8 weeks. H. pylori was effectively eradicated in 85.7% (36/42) of patients. Conclusions: The results suggested that the combination therapy for open gastric ulcer was safe, well-tolerated and effective. However, data from a double-blind placebo-controlled study is necessary to confirm these findings.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume21
Issue number1 PART1
DOIs
Publication statusPublished - 2006 Jan

Keywords

  • Gastric ulcer
  • Helicobacter pylori
  • Pepsinogen
  • Rebamipide
  • Ulcer healing

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide'. Together they form a unique fingerprint.

Cite this